Private Advisory Group LLC Makes New $834,000 Investment in Vital Farms, Inc. $VITL

Private Advisory Group LLC bought a new stake in Vital Farms, Inc. (NASDAQ:VITL) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 20,270 shares of the company’s stock, valued at approximately $834,000.

A number of other hedge funds have also recently modified their holdings of the stock. Royal Bank of Canada boosted its stake in Vital Farms by 89.2% in the first quarter. Royal Bank of Canada now owns 19,381 shares of the company’s stock valued at $591,000 after acquiring an additional 9,136 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Vital Farms by 5.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,057 shares of the company’s stock valued at $611,000 after purchasing an additional 1,108 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Vital Farms by 3.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 415,420 shares of the company’s stock valued at $12,658,000 after purchasing an additional 13,397 shares during the period. Woodline Partners LP purchased a new position in Vital Farms during the 1st quarter worth approximately $1,073,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Vital Farms by 1.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 89,893 shares of the company’s stock worth $2,739,000 after buying an additional 1,198 shares during the last quarter. 98.59% of the stock is owned by hedge funds and other institutional investors.

Vital Farms Price Performance

Shares of NASDAQ VITL opened at $25.57 on Tuesday. The stock has a fifty day moving average price of $29.33 and a 200 day moving average price of $36.62. Vital Farms, Inc. has a 1-year low of $25.42 and a 1-year high of $53.13. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.65 and a quick ratio of 2.15. The company has a market cap of $1.15 billion, a PE ratio of 19.37 and a beta of 1.10.

Insider Buying and Selling at Vital Farms

In other news, insider Matthew Ohayer sold 20,000 shares of Vital Farms stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $27.91, for a total value of $558,200.00. Following the sale, the insider owned 6,341,190 shares of the company’s stock, valued at $176,982,612.90. The trade was a 0.31% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Russell Diez-Canseco sold 16,734 shares of the stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $35.05, for a total transaction of $586,526.70. Following the transaction, the chief executive officer directly owned 649,684 shares of the company’s stock, valued at $22,771,424.20. This represents a 2.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 91,734 shares of company stock valued at $2,921,477 in the last 90 days. Company insiders own 21.30% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. BMO Capital Markets reduced their price objective on Vital Farms from $60.00 to $50.00 and set an “outperform” rating for the company in a research note on Thursday, December 18th. Needham & Company LLC reaffirmed a “buy” rating and issued a $45.00 target price on shares of Vital Farms in a report on Friday, January 30th. Telsey Advisory Group reiterated an “outperform” rating and issued a $50.00 price target on shares of Vital Farms in a research report on Tuesday, January 13th. Zacks Research downgraded shares of Vital Farms from a “strong-buy” rating to a “hold” rating in a research report on Friday, November 14th. Finally, Morgan Stanley dropped their price objective on shares of Vital Farms from $48.00 to $45.00 and set an “overweight” rating on the stock in a research note on Wednesday, December 17th. Twelve investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $49.91.

Vital Farms Company Profile

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.